These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 17700285

  • 1. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
    Yazdani S, Hendi K, Pakravan M.
    J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
    [Abstract] [Full Text] [Related]

  • 2. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
    Douat J, Auriol S, Mahieu-Durringer L, Ancèle E, Pagot-Mathis V, Mathis A.
    J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab in a patient with neovascular glaucoma.
    Kahook MY, Schuman JS, Noecker RJ.
    Ophthalmic Surg Lasers Imaging; 2006 Nov; 37(2):144-6. PubMed ID: 16583637
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
    Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM.
    Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
    dell'Omo R, Kulkarni A, Franks WA.
    Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y.
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [Abstract] [Full Text] [Related]

  • 9. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
    Saito Y, Higashide T, Takeda H, Murotani E, Ohkubo S, Sugiyama K.
    Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
    [Abstract] [Full Text] [Related]

  • 10. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
    Alkawas AA, Shahien EA, Hussein AM.
    J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma.
    Yuzbasioglu E, Artunay O, Rasier R, Sengul A, Bahcecioglu H.
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):259-64. PubMed ID: 19348598
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
    Vatavuk Z, Bencic G, Mandic Z.
    Eur J Ophthalmol; 2007 Jun; 17(2):269-71. PubMed ID: 17415704
    [Abstract] [Full Text] [Related]

  • 14. Bevacizumab (Avastin) for the treatment of neovascular glaucoma.
    Chilov MN, Grigg JR, Playfair TJ.
    Clin Exp Ophthalmol; 2007 Jul; 35(5):494-6. PubMed ID: 17651259
    [Abstract] [Full Text] [Related]

  • 15. Intracameral bevacizumab for iris rubeosis.
    Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU, Tuebingen Bevacizumab Study Group.
    Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
    [Abstract] [Full Text] [Related]

  • 16. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma.
    Wasik A, Song HF, Grimes A, Engelke C, Thomas A.
    Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ.
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.
    Retina; 2006 May; 26(5):495-511. PubMed ID: 16770255
    [Abstract] [Full Text] [Related]

  • 20. Bevacizumab as adjuvant for neovascular glaucoma.
    Beutel J, Peters S, Lüke M, Aisenbrey S, Szurman P, Spitzer MS, Yoeruek E, Bevacizumab Study Group, Grisanti S.
    Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.